Daniel Miller M.D., Surgical Director at Winship Cancer Institute of Emory University

Daniel Miller M.D.

Surgical Director, Thoracic Oncology Program

About Daniel Miller

Atlanta, Georgia's Emory University School of Medicine has long attracted the highest caliber of professionals. Daniel L. Miller, M.D, the facility's chief of General Thoracic Surgery and surgical director of the Thoracic Oncology Program at the hospital's Winship Cancer Institute, is considered to be one of the world's leading authorities on lung cancer and mesothelioma.

Get in touch

Accolades

Pleural and Lung Cancer icon

Pleural and Lung Cancer

Research Excellence icon

Excellence in Research

Team Leader icon

Team Leader

Minimally Invasive Surgery icon

Minimally Invasive Surgery

His goal is a minimally invasive treatment program for thoracic malignancies, including lung cancer and mesothelioma. He’s succeeded in using CT scans to detect and analyze small non-small lung cancers, and treating malignant pleural effusions with hyperthermic pleural lavage. He’s applying proteomics to diagnose malignant mesothelioma based on the pleural fluid of patients exposed to high asbestos levels.

More About

Daniel Miller M.D.

Specialty

General Thoracic Surgery

Medical Treatment Center

Cancer Treatment Centers of America

Contact

Get in touch

Trimodal Therapy

Quick Fact

Throughout his career, Miller has completed surgeries such as laparoscopic anti-reflux surgery, lobectomy and lung transplantation.

His main focus is utilizing trimodal therapy for malignant pleural mesothelioma, in which induction chemotherapy is given, followed by extrapleural pneumonectomy (removing affected lung tissue, along with affected diaphragm, chest and/or heart lining portions) and then adjuvant radiation.

Miller, who has received numerous honors and awards for his work, and his Emory colleagues have their own recommendations for treating malignant mesothelioma.

“Our preference is single-port thoracoscopy at the time of diagnosis,” Miller said. “We also recommend delaying any chemical pleurodesis until the postchemotherapy mediastinoscopy assessment.”

I think for all of us who deal with mesothelioma, the number one objective is to have the patient to complete trimodality therapy as planned, which offers the best chance for cure.”

– Daniel Miller M.D.

Miller’s Publications

Miller’s publications primarily address surgical topics for lung cancer, mesothelioma and other related malignancies. In 2011, his article “Impact of Laterality on Early and Late Survival after Pneumonectomy” was published in the Annals of Thoracic Surgery.

Disclaimer: Dr. Daniel Miller has no professional affiliation with Asbestos.com.

Locate the Best Mesothelioma Doctor for You

Find a Specialist
Asbestos.com Mesothelioma Packet

Learn All About Mesothelioma Treatment

Order Your Free Guide

Find a Clinical Trial Near You

Get Help Now
  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Daniel Miller
Get Help Contacting Daniel Miller
Get Your Free Mesothelioma Guide Chat live with a patient advocate now loading spinner